Stage 3 Cervical Cancer — What It Means and How It Is Treated

Why Stage 3 Is Four Situations Under One Number

Stage 3 is the least intuitive of the cervical cancer stages, because it is not simply “bigger than stage 2”. It is a group of findings, any one of which is enough on its own. A tumour that has crept down into the lower third of the vagina qualifies. So does one that has grown sideways as far as the pelvic side wall. So does one that has squeezed a ureter closed, causing the kidney above it to swell or lose function. And since the 2018 revision, so does cancer found in the pelvic or para-aortic lymph nodes — whatever the size of the tumour in the cervix.

That last route is the one that confuses people most. Women are told the cervical tumour is small, sometimes only a couple of centimetres, and then told the stage is 3. Both statements are true. FIGO 2018 decided that nodal spread carries more weight in predicting outcome than local size does, so a node-positive case is recorded as stage IIIC regardless. It is a change in bookkeeping that reflects biology, not a sign that something was missed earlier. How lymph node involvement is assessed covers that in detail.

What all four situations share is that the disease is still inside the pelvis and its immediate drainage pathway. That is why stage 3 sits with stage 2 under the heading locally advanced, and why the treatment framework is the same: radiation to the pelvis with chemotherapy given alongside it, finished with brachytherapy. It is emphatically not the same as stage 4, where disease has reached the bladder, the rectum or an organ outside the pelvis. For the staging system as a whole, read FIGO staging explained, and for the disease in general the cervical cancer overview.

The Four Sub-Stages of Stage 3

Any one of these findings assigns stage 3. Where more than one is present, the highest applies.

Tumour type is recorded alongside stage. Most stage 3 disease is squamous cell carcinoma, with adenocarcinoma treated on the same framework.

What the Team Checked Before Confirming Stage 3

Because four separate findings can each assign stage 3, the work-up deliberately looks for all of them.

How Stage 3 Cervical Cancer Is Treated

Every sub-stage of stage 3 is treated with concurrent chemoradiation completed by brachytherapy. What changes between them is the size and shape of the radiation field, and what has to be sorted out before treatment can begin.

The chemotherapy given during radiation is a platinum-based agent delivered as a weekly infusion, given to make the tumour more sensitive to radiation rather than to shrink it on its own. For some women with high-risk locally advanced disease, current guidance also includes an immunotherapy that targets the PD-1 checkpoint alongside and after chemoradiation. Whether that applies to you depends on your stage details and your tumour’s PD-L1 status — the specifics, schedules and costs are set out on our cervical cancer treatment in Hyderabad page.

Brachytherapy: the Part of the Course That Decides the Most

External beam radiation treats the pelvis broadly. Brachytherapy treats the cervix intensely. An applicator is placed into the cervix and upper vagina, its position is confirmed on imaging, and a sealed radiation source is then driven through it so a very high dose lands on the tumour while the bladder and rectum — only centimetres away — receive a fraction of it. Where the tumour extends sideways, thin interstitial needles are added so the dose reaches the edges of the disease rather than stopping short.

Two things make this the most consequential part of stage 3 treatment. The first is that no external beam technique reaches the same dose at the cervix without unacceptable damage around it, which is why guidance treats brachytherapy as a required component rather than an optional boost. The second is that it is adaptive: the plan is recalculated at each session against imaging taken that day, so the dose follows the tumour as it shrinks in response to the earlier weeks of treatment.

It is also the part women worry about most, largely because so little is explained in advance. The applicator placement is done under anaesthesia or sedation; there is usually a period of lying still afterwards; and it is repeated over a small number of sessions rather than daily. Our guide to what brachytherapy is actually like walks through the day itself, the pain relief used and what recovery in between sessions involves. If you are choosing where to be treated, ask directly whether image-guided brachytherapy is performed on site — it is a fair question and a decisive one.

Getting Through the Course, and What Comes After

A stage 3 course runs roughly eight weeks from planning to the final brachytherapy session, and finishing it within that window matters. Gaps let surviving tumour cells recover between sessions, and prolonged courses are associated with poorer local control. Most interruptions are avoidable: low blood counts, infections, dehydration from diarrhoea, and travel problems account for the majority. All four are manageable if flagged early, which is the single most useful thing you can do during treatment — report problems while they are small rather than missing an appointment and rescheduling quietly.

Expect fatigue that builds week on week, looser and more frequent motions, bladder irritation and soreness in the skin folds. Weekly blood tests check counts and kidney function before each infusion. Where an extended field has been used for para-aortic nodes, nausea and low counts tend to be somewhat more pronounced because more bowel and bone marrow sit inside the treated volume. Nutrition support and anti-sickness medication are part of the plan, not an afterthought, and pain from pelvic disease usually eases within the first two to three weeks as the tumour responds.

Afterwards, the first assessment is usually around three months later with an MRI to judge response, then clinical examination every three to four months for the first two years. Vaginal dryness and narrowing are managed actively with a dilator and moisturiser started a few weeks after the course ends — ask for instructions before you are discharged. Across the cervical cancer patients treated at CION, 1-year survival is 83.3% against a national figure of 67.3%, a gap driven largely by protocol-led planning and by patients completing the full course rather than stopping partway.

Why Women With Stage 3 Cervical Cancer Choose CION

At stage 3 the things that change outcomes are unglamorous: a well-shaped plan, brachytherapy on site, and nothing interrupting the schedule.

Start Treatment Knowing Exactly What Is Ahead

Bring your MRI, your PET-CT and your blood reports. You will leave with the schedule, the side effects and the cost written down — and a plan agreed by a full oncology team.

Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It describes how stage 3 cervical cancer is generally staged and treated and cannot substitute for advice based on your own reports. Treatment decisions should be made with the oncology team that has examined you and reviewed your pathology and imaging.